The Patent Finder

VTV Therapeutics LLC

70 patents currently held · Updated Nov 17, 2026
7 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Transtech Pharma, Inc. (to 2015)

31
Ending by 2030
Dec 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 2, 2026
    The maintenance fee for Phenyl-Heteroaryl Derivatives and Methods of Use Thereof (US 9,045,461) comes due Dec 2, 2026. Unpaid by Jun 2, 2027, it lapses early.
  • 1 fee due Jan 30, 2027
    The maintenance fee for Piperidine Derivative and Methods of Use Thereof (US 10,364,233) comes due Jan 30, 2027. Unpaid by Jul 30, 2027, it lapses early.
  • 1 fee due Feb 27, 2027
    The maintenance fee for Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors (US 10,391,097) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
  • 1 fee due Mar 1, 2027
    The maintenance fee for Oxadiazoanthracene Compounds for the Treatment of Diabetes (US 9,120,813) comes due Mar 1, 2027. Unpaid by Sep 1, 2027, it lapses early.
  • 2 fees due Apr 20 to 29, 2027 · next Apr 20
  • 2 fees due May 3 to 5, 2027 · next May 3
  • 2 fees due Jun 1 to 5, 2027 · next Jun 1
  • 1 fee due Jul 30, 2027
    The maintenance fee for Pharmaceutically Acceptable Salts of [3-(4- {2-Butyl-1-[4-(4-Chloro-PHENOXY)-PHENYL]-1H-IMIDAZOL-4-YL} -Phenoxy)-Propyl]-Diethyl-Amine (US 11,883,383) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
  • 2 fees due Aug 25, 2027
  • 1 fee due Oct 30, 2027
    The maintenance fee for Metabolites of [3-(4-(2-Butyl-1-[4-(4-Chloro-PHENOXY)-PHENYL]-1H-IMIDAZOL-4 Yl)-Phenoxy)-Propyl]-Diethyl-Amine (US 11,970,457) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.
  • 1 fee due Nov 7, 2027
    The maintenance fee for Therapeutic Uses of Glucokinase Activators in Combination with Insulin or Insulin Analogs (US 11,974,989) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,362,016Phenyl Propionic Acids as Ppar Delta Activators
In force
 · High confidence
In forceHigh confidence
US 8,551,993Phenoxy Acetic Acids as Ppar Delta Activators
In force
 · High confidence
In forceHigh confidence
US 9,663,481Phenoxy Acetic Acids and Phenyl Propionic Acids as Ppar Delta Agonists
In force
 · High confidence
In forceHigh confidence
US 10,471,066Phenoxy Acetic Acids and Phenyl Propionic Acids as Ppar Delta Agonists
In force
 · High confidence
In forceHigh confidence
US 10,947,180Phenoxy Acetic Acids and Phenyl Propionic Acids as Ppar Delta Agonists
In force
 · High confidence
In forceHigh confidence
US 11,420,929Phenoxy Acetic Acids and Phenyl Propionic Acids as Ppar Delta Agonists
In force
 · High confidence
In forceHigh confidence
US 7,943,613Novel Compounds, Their Preparation and Use
In force
 · High confidence
In forceHigh confidence
US 8,586,614Urea Glucokinase Activators
In force
 · Medium confidence
In forceMedium confidence
US 8,318,778Urea Glucokinase Activators
In force
 · High confidence
In forceHigh confidence
US 8,362,049Urea Glucokinase Activators
In force
 · High confidence
In forceHigh confidence
10 of 70 patents shown.
Pro members see all 70.
Pro members: see all 70 patents
Also on record, not counted in the 70: 7 patents in force now held by others · 57 lapsed for an unpaid fee · 9 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 16 abandoned

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited